Esophagus to Small Intestine
Clin Gastroenterol Hepatol. 2024;22(3):523–31.e3
Prevalence and predictors of Barrett’s esophagus after negative initial endoscopy: Analysis from 2 national databases
Background and aims: Guidelines suggest a single screening esophagogastroduodenoscopy (EGD) in patients with multiple risk factors for Barrett’s esophagus (BE). The authors aimed to determine BE prevalence and predictors on repeat EGD after a negative initial EGD, using 2 large national databases (GI Quality Improvement Consortium [GIQuIC] and TriNetX).
Methods: Patients who underwent at least 2 EGDs were included and those with BE or esophageal adenocarcinoma detected at initial EGD were excluded. Patient demographics and prevalence of BE on repeat EGD were collected. Multivariate logistic regression was performed to assess for independent risk factors for BE detected on the repeat EGD.
Results: In 214,318 and 153,445 patients undergoing at least 2 EGDs over a median follow-up of 28–35 months, the prevalence of BE on repeat EGD was 1.7% in GIQuIC and 3.4% in TriNetX, respectively (26–45% of baseline BE prevalence). Most patients (89%) had non-dysplastic BE. The prevalence of BE remained stable over time (from 1 year to > 5 years from negative initial EGD) but increased with increasing number of risk factors. BE prevalence in a high-risk population (gastroesophageal reflux disease plus ≥ 1 risk factor for BE) was 3–4%.
Conclusions: In this study of > 350,000 patients, rates of Barrett’s esophagus (BE) on repeat esophagogastroduodenoscopy ranged from 1.7–3.4%, and were higher in those with multiple risk factors. Most were likely missed at initial evaluation, underscoring the importance of a high-quality initial endoscopic examination. Although routine repeat endoscopic BE screening after a negative initial examination is not recommended, repeat screening may be considered in carefully selected patients with gastroesophageal reflux disease and ≥ 2 risk factors for BE, potentially using non-endoscopic tools.